Wikipedia

Hantavirus

Hantavirus
Classification and external resources
ICD-10B33.4
ICD-9079.81
DiseasesDB5629
MedlinePlus001382
MeSHD018778

Hantaviruses are single-stranded, enveloped, negative sense RNA viruses in the Bunyaviridae family. They normally infect rodents and don't cause disease in these hosts. Humans may become infected with hantaviruses through contact with rodent urine, saliva, or feces. Some strains of hantaviruses cause potentially fatal diseases in humans, such as Hantavirus hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS), while others have not been associated with known human disease.[1]

Human infections of hantaviruses have almost entirely been linked to human contact with rodent excrement, but recent human-to-human transmission has been reported with the Andes virus in South America.[1]

Hantavirus is named for the Hantan River area in South Korea where an early outbreak was observed. The virus was isolated in the late 1970s by Karl M. Johnson and Ho-Wang Lee.[2][3][4][5]

History[edit]

The hantaviruses are a relatively newly discovered genus of viruses. An outbreak of Korean Hemorrhagic Fever among American and Korean soldiers during the Korean War (1950–1953) was later found to be caused by a hantavirus infection. More than 3000 troops became ill with symptoms that included renal failure, generalized hemorrhage, and shock. It had a 10% mortality rate. This outbreak sparked a 25-year search for the etiologic agent. Ho-Wang Lee, a South Korean virologist, Karl M. Johnson, an American tropical virologist, and his colleagues isolated Hantaan virus in 1976 from the lungs of striped field mice.[6][7]

In late Medieval England a mysterious sweating sickness swept through the country in 1485 just before the Battle of Bosworth Field. Noting the similar symptoms which overlap with Hantavirus pulmonary syndrome (HPS, see below), several scientists have theorised that the virus may have been the cause of the disease.[8][9] The hypothesis was criticised because sweating sickness was recorded as being transmitted human-to-human whereas hantaviruses were not known to spread in this way.[10] Limited transmission via human-to-human contact has since been shown in Hantavirus outbreaks in Argentina.[11]

In 1993, an outbreak of Hantavirus pulmonary syndrome occurred in the Four Corners region in the southwestern United States. The viral cause of the disease was found only weeks later and was called the Sin Nombre virus (SNV, in Spanish, "Virus sin nombre", for "nameless virus"). Its rodent host, the Deer mouse (Peromyscus maniculatus), was first identified by Terry Yates, a professor at the University of New Mexico.[12]

Two major clinical syndromes[edit]

Hemorrhagic fever with renal syndrome[edit]

Hemorrhagic fever with renal syndrome (HFRS) is a group of clinically similar illnesses caused by species of hantaviruses from the family Bunyaviridae. It is also known as Korean hemorrhagic fever, epidemic hemorrhagic fever, and nephropathis epidemica. The species that cause HFRS include Hantaan River, Dobrava-Belgrade, Saaremaa, Seoul, and Puumala. It is found in Europe, Asia, and Africa.

In hantavirus induced hemorrhagic fever, incubation time is between two to four weeks in humans before symptoms of infection present. Severity of symptoms depends on the viral load.[13]

Hantavirus pulmonary syndrome[edit]

Hantavirus pulmonary syndrome (HPS) is found in North, Central and South America.[14] It is an often fatal pulmonary disease. In the United States, the causative agent is Sin Nombre virus carried by deer mice. Prodromal symptoms include flu-like symptoms such as fever, cough, myalgia, headache, and lethargy. It is characterized by a sudden onset of shortness of breath with rapidly evolving pulmonary edema that is often fatal despite mechanical ventilation and intervention with potent diuretics. It has a fatality rate of 36%.[15]

Hantavirus pulmonary syndrome was first recognized during the 1993 outbreak in the Four Corners region of the southwestern United States. It was identified by Dr. Bruce Tempest. It was originally called "Four Corners disease," but the name was changed to Sin Nombre virus after complaints by Native Americans that the name 'Four Corners' stigmatized the region.[16] It has since been identified throughout the United States. Rodent control in and around the home remains the primary prevention strategy.

Epidemiology[edit]

Regions especially affected by hemorrhagic fever with renal syndrome include China, the Korean Peninsula, Russia (Hantaan, Puumala and Seoul viruses), and northern and western Europe (Puumala and Dobrava virus). Regions with the highest incidences of hantavirus pulmonary syndrome include Patagonia Argentina, Chile, Brazil, the United States, Canada, and Panama.

Asia[edit]

In China, the Korean Peninsula, and Russia, hemorrhagic fever with renal syndrome is caused by Hantaan, Puumala and Seoul viruses. Korean Hemorrhagic Fever was first documented during the Korean War when American troops became ill.

South America[edit]

The two agents of HPS in South America are Andes virus (also called Oran, Castelo de Sonhos, Lechiguanas, Juquitiba, Araraquara, and Bermejo viruses, among many other synonyms), which is the only hantavirus that has shown (albeit uncommonly) an interpersonal form of transmission, and Laguna Negra virus, an extremely close relative of the previously-known Rio Mamore virus.

Rodents that have been shown to carry hantaviruses include Abrothrix longipilis and Oligoryzomys longicaudatus.[17]

North America[edit]

In the U.S., minor cases of HPS include Sin Nombre virus, New York virus, Bayou virus, and possibly Black Creek Canal virus.

In the United States, as of July 2010 eight states had reported 30 or more cases of Hantavirus since 1993[18] – New Mexico (84), Colorado (70), Arizona (62), California (42), Washington (41), Texas (37), Utah (31) and Montana (30). Other states reporting a significant number of cases include Idaho (16), Kansas (15), South Dakota (15), North Dakota (12) and Oregon (11).

In late August and early September of 2012, eight new cases of Hantavirus were confirmed, including three deaths, in the Curry Village area of Yosemite National Park.[19] On Long Island, David Hartstein, a chiropractor, died in June 2011, after contracting hantavirus. His story is featured in the HBO documentary Hard Times, Lost on Long Island.[20]

In addition to infecting rodents hantaviruses are known to be carried by shrews (order Soricomorpha, family Soricidae) and moles (family Talpidae).[21]

In Mexico a number of rodents have been found to carry hantaviruses: Megadontomys thomasi, Neotoma picta, Peromyscus beatae, Reithrodontomys megalotis and Reithrodontomys sumichrasti.[22]

In Canada, there was one confirmed death in Northern British Columbia in January, 2013 and at least one confirmed death in Kindersley, Saskatchewan, in June 2013.[23] Another death in the Kindersley area (June 2013) may also be linked to Hantavirus. One confirmed case (July 2013) in Burr, Saskatchewan (near Kindersley); the patient was gravely ill but survived.

Europe[edit]

In Europe three hantaviruses - Puumala, Dobrava and Saaremaa viruses - are known to cause haemorrhagic fever with renal syndrome.[24] Puumala usually causes a generally mild disease - nephropathia epidemica - which typically presents with fever, headache, gastrointestinal symptoms, impaired renal function and blurred vision. Dobrava infections while similar often also have haemorrhagic complications. There are few reports of confirmed Saaremaa infections but these appear to be similar to those caused by Puumala and less pathogenic than Dobrava.

Puumala is carried by its rodent host, the bank vole (Clethrionomys glareolus) and is present through most of Europe excluding the Mediterranean region. Dobrava and Saaremaa carried respectively by the yellow necked mouse (Apodemus flavicollis) and the striped field mouse (Apodemus agrarius) are reported mainly in eastern and central Europe.

Africa[edit]

A novel hantavirus, Sangassou virus has been isolated in Africa that causes hemorrhagic fever with renal syndrome.[25]

Prevention and treatment[edit]

There is no known antiviral treatment, but natural recovery from the virus is possible with supportive treatment. Patients with suspected hantavirus are usually admitted to the hospital and given oxygen and mechanical ventilation support to help them breathe during the acute pulmonary stage.[26] As the virus can be transmitted by rodent saliva, excretia, and bites, control of rats and mice in areas frequented by humans is key for disease prevention. General prevention can be accomplished by disposing of rodent nests, sealing any cracks and holes in homes where mice or rats could get in, setting up traps, laying down poisons or using natural predators such as cats in the home.[26]

Leptospirosis causes similar symptoms and is also carried by rodent vectors, but it is due to a bacterial spirochete rather than a virus. Presumptive treatment of leptospirosis with penicillin (and other) antibiotics is often started for severe symptoms when a diagnostic dilemma between the two diseases is encountered.

Virology[edit]

Classification[edit]

Hantaviruses are Bunyaviruses. The Bunyaviridae family is divided into five genera: Orthobunyavirus, Nairovirus, Phlebovirus, Tospovirus, and Hantavirus. Like all members of this family, hantaviruses have genomes comprising three negative-sense, single-stranded RNA segments, and so are classified as negative sense RNA viruses. Members of other Bunyaviridae family genera are generally arthropod-borne viruses,[27] but hantaviruses are thought to be transmitted to humans mainly through inhalation of aerosolized rodent excreta or rodent bites.

Genome[edit]

Like other members of the bunyavirus family, hantaviruses are enveloped viruses with a genome that consists of three single-stranded, negative sense RNA segments designated S (small), M (medium), and L (large). The S RNA encodes the nucleocapsid (N) protein. The M RNA encodes a polyprotein that is cotranslationally cleaved to yield the envelope glycoproteins Gn (formerly G1) and Gc (formerly G2).[27][28]

The L RNA encodes the L protein, which functions as the viral transcriptase/replicase. Within virions, the genomic RNAs of hantaviruses are thought to complex with the N protein to form helical nucleocapsids, the RNA component of which circularizes due to sequence complementarity between the 5' and 3' terminal sequences of genomic segments.

As with other Bunyaviridae, each of the three segments has a consensus 3'-terminal nucleotide sequence (AUCAUCAUC), which is complementary to the 5' terminal sequence and is distinct from those of the other four genera in the family.[29] These sequences appear to form panhandle structures which seem likely to play a role in replication and encapsidation facilitated by binding with the viral nucleocapsid (N) protein.[30] The large segment is 6530-6550 nucleotides (nt) in length, the medium is 3613-3707 nt in length and the small is 1696-2083 nt in length.

No nonstructural proteins are known unlike the other genera in this family. At the 5' and 3' of each segment are short noncoding sequences: the noncoding segment in all sequences at the 5' end is 37-51 nt. The 3' noncoding regions differ: L segment 38-43 nt; M segment 168-229 nt; and S segment 370-730 nt. The 3' end of the S segment is conserved between the genera suggesting a functional role.

Virions[edit]

Hantavirus virions are about 120-160 nanometers (nm) in diameter. The lipid bilayer of the viral envelope is about five nm thick and is embedded with viral surface proteins to which sugar residues are attached. These glycoproteins, known as Gn and Gc, are encoded by the M segment of the viral genome. They tend to associate (heterodimerize) with each other and have both an interior tail and an exterior domain that extends to about six nm beyond the envelope surface.

Inside the envelope are the nucleocapsids. These are composed of many copies of the nucleocapsid protein N, which interact with the three segments of the viral genome to form helical structures. The virally encoded RNA polymerase is also found in the interior. By mass, the virion is greater than 50% protein, 20-30% lipid and 2-7% carbohydrate. The density of the virions is 1.18 gram per cubic centimeter. These features are common to all members of the Bunyaviridae.

Life cycle[edit]

Entry into host cells is thought to occur by attachment of virions to cellular receptors and subsequent endocytosis. Nucleocapsids are introduced into the cytoplasm by pH-dependent fusion of the virion with the endosomal membrane. Subsequent to release of the nucleocapsids into cytoplasm, the complexes are targeted to the ER-Golgi Intermediate compartments (ERGIC) through microtubular associated movement resulting in the formation of viral factories at ERGIC.

These factories then facilitate transcription and subsequent translation of the viral proteins. Transcription of viral genes must be initiated by association of the L protein with the three nucleocapsid species. In addition to transcriptase and replicase functions, the viral L protein is also thought to have an endonuclease activity that cleaves cellular messenger RNAs (mRNAs) for the production of capped primers used to initiate transcription of viral mRNAs. As a result of this "cap snatching," the mRNAs of hantaviruses are capped and contain nontemplated 5' terminal extensions.

The G1 (aka Gn) and G2 (Gc) glycoproteins form hetero-oligomers and are then transported from the endoplasmic reticulum to the Golgi complex, where glycosylation is completed. The L protein produces nascent genomes by replication via a positive-sense RNA intermediate. Hantavirus virions are believed to assemble by association of nucleocapsids with glycoproteins embedded in the membranes of the Golgi, followed by budding into the Golgi cisternae. Nascent virions are then transported in secretory vesicles to the plasma membrane and released by exocytosis.

The cotton rat, Sigmodon hispidus, is a hantavirus carrier that becomes a threat when it enters human habitation in rural and suburban areas.

Pathogenesis[edit]

The pathogenesis of Hantavirus infections is unclear as there is a lack of animal models to describe it (rats and mice do not seem to acquire severe disease). While the primary site of viral replication in the body is not known, in HFRS the main effect is in the blood vessels while in HPS most symptoms are associated with the lungs. In HFRS, there are increased vascular permeability and decreased blood pressure due to endothelial dysfunction and the most dramatic damage is seen in the kidneys, whereas in HPS, the lungs, spleen, and gall bladder are most affected. Early symptoms of HPS tend to present similarly to the flu (muscle aches, fever and fatigue) and usually show up around 2 to 3 weeks after exposure. Later stages of the disease (about 4 to 10 days after symptoms start) will include difficulty breathing, shortness of breath and coughing.[26]

Transmission[edit]

The species that cause hantavirus hemorrhagic fever have not been shown to transfer from person to person. Transmission by aerosolized rodent excreta still remains the only known way the virus is transmitted to humans. Similar negative-stranded RNA viruses, such as Marburg and Ebola hemorrhagic fevers, can be transmitted by contact with infected blood and body fluids, and are known to spread to patient-care workers in African hospitals. But those viruses do not transfer readily in the modern hospital setting with universal precautions. Fomite transfer has not been shown in the hantaviruses in either the hemorrhagic or pulmonary forms.[31][32]

Evolution[edit]

Findings of significant congruence between phylogenies of hantaviruses and phylogenies of their rodent reservoirs have led to the theory that rodents, although infected by the virus are not harmed by it because of long-standing hantavirus-rodent host coevolution.[27][33] However, recent findings have led to scientific debate and new hypotheses regarding hantavirus evolution.[28][34]

Various hantaviruses have been found to infect multiple rodent species, and cases of cross-species transmission (host switching) have been recorded.[35][36][37] Additionally, rates of substitution based on nucleotide sequence data reveal that hantavirus clades and rodent subfamilies may not have diverged at the same time.[34][38] Furthermore, hantaviruses have been found in multiple species of shrews and moles.[34][39][40][41]

Taking into account the inconsistencies in the theory of coevolution, Ramsden et al. (2009) have proposed that the patterns seen in hantaviruses in relation to their reservoirs could be attributed to preferential host switching directed by geographical proximity and adaptation to specific host types.[34] Ulrich et al. (2010) have proposed that the observed geographical clustering of hantavirus sequences may have been caused by an isolation-by-distance mechanism.[37] Upon comparison of the hantaviruses found in hosts of orders Rodentia and Soricomorpha, Yanagihara et al. (2011) have proposed that the evolutionary history of the hantavirus consists of a complex mix of both host switching and codivergence and suggest that ancestral shrews or moles rather than rodents may have been the early original hosts of ancient hantaviruses.[39]

A Bayesian analysis suggests a common origin for these viruses ~2000 years ago.[42] The association with particular rodent families appears to have been more recent. The viruses carried by the Arvicolinae and Murinae subfamilies originated in Asia 500–700 years ago. These subsequently spread to Africa, Europe, North America and Siberia possibly carried by their hosts. The species infecting the Neotominae subfamily evolved 500–600 years ago in Central America. These species then spread toward North America. The species infecting Sigmodontinae evolved in Brazil 400 years ago. Their ancestors may have been a Neotominae associated virus from northern South America.

Vaccine Research[edit]

The Korean Army is one of the largest consumers of the hantavirus vaccine, second only to public health centers. There are more than 20 recognized hantaviruses, some of which are associated with one of two serious human diseases: hemorrhagic fever with renal syndrome (HFRS) or hantavirus pulmonary syndrome (HPS). Efforts are continuing to develop safe and effective hantavirus vaccines. Several classical and molecular vaccine approaches are in pre-clinical stages of development. The development of hantavirus vaccines is hampered by the lack of adequate animal models of hantavirus-associated disease. No specific antiviral therapy is yet available. No hantavirus vaccine has been approved for use in the US, and no WHO-approved vaccine has gained widespread acceptance.[43]

See also[edit]

References[edit]

  1. ^ a b Martinez, V. P.; Bellomo, C.; San Juan, J.; Pinna, D.; Forlenza, R.; Elder, M.; Padula, P. J. (2005). "Person-to-person transmission of Andes virus". Emerging Infectious Diseases 11 (12): 1848–1853. doi:10.3201/eid1112.050501. PMID 16485469. 
  2. ^ Johnson KM (2001). "Hantaviruses: history and overview". Current topics in microbiology and immunology (256): 1–14. PMID 11217399. 
  3. ^ Schmaljohn C, Hjelle B (1997). "Hantaviruses: a global disease problem". Emerging Infectious Diseases 3 (2): 95–104. doi:10.3201/eid0302.970202. PMID 9204290. 
  4. ^ Lee HW (1989). "Hemorrhagic fever with renal syndrome in Korea". Reviews of infectious diseases 11 (Suppl 4): S864–76. PMID 2568676. 
  5. ^ Lee, HW; Lee, PW; Johnson, KM (1978). "Isolation of the etiologic agent of Korean Hemorrhagic fever". The Journal of infectious diseases 137 (3): 298–308. doi:10.1093/infdis/137.3.298. PMID 24670. 
  6. ^ "Hantavirus infection—haemorrhagic fever in the Balkans—potential nephrological hazards in the Kosovo war". Ndt.oxfordjournals.org. 2013-04-04. Retrieved 2013-04-13. 
  7. ^ Lee HW, Baek LJ, Johnson KM. Isolation of Hantaan virus, the etiologic agent of Korean hemorrhagic fever, from wild urban rats. J Infect Dis 1982; 146: 638–644
  8. ^ Thwaites, Guy; Taviner, Mark; Gant, Vanya (1997). "The English Sweating Sickness, 1485 to 1551". New England Journal of Medicine 336 (8): 580–582. doi:10.1056/NEJM199702203360812. PMID 9023099. 
  9. ^ Taviner, M; Thwaites, G.; Gant, V. (1998). "The English sweating sickness, 1485-1551: a viral pulmonary disease?". Medical History (Department of Modern History. St Andrews University, London) 42 (1): 96–98. doi:10.1017/S0025727300063365. PMC 1043971. PMID 9536626. 
  10. ^ Bridson, Eric (2001). "English 'sweate' (Sudor Anglicus) and Hantavirus pulmonary syndrome, The". British Journal of Biomedical Science. 
  11. ^ Padula, P; Edelstein A; Miguel SD; López NM; Rossi CM; Rabinovich RD. (February 15, 1998). "Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus". Virology (London: Elsevier) 241 (2): 323–330. doi:10.1006/viro.1997.8976. PMID 9499807. 
  12. ^ Schudel, Matt (2007-12-24). "Terry Yates, 57; biologist found source of hantavirus". Washington Post (Boston Globe). Retrieved 2007-01-04. 
  13. ^ Yi J., Xu Z., Zhuang R., Wang J., Zhang Y., Ma Y., Liu B., Zhang Y., Zhang C., Yan G., Zhang F., Xu Z., Yang A. and Jin B. (2013). "Hantaan River Virus RNA Load in Patients Having Hemorrhagic Fever With Renal Syndrome: Correlation With Disease Severity". Journal of Infectious Disease (Oxford Journals) 207 (9): 1457–1461. doi:10.1093/infdis/jis475. 
  14. ^ "CDC - Hantavirus Pulmonary Syndrome (HPS) – Hantavirus". Cdc.gov. 2013-02-06. Retrieved 2013-04-13. 
  15. ^ "Reported Cases of HPS: HPS in the United States". Centers for Disease Control and Prevention (CDC). 21 April 2014. Retrieved 04-08-2014. 
  16. ^ "Death at the Corners". DiscoverMagazine.com. 1 December 1993. Retrieved 2013-03-25. 
  17. ^ Medina, R. A.; Torres-Perez, F.; Galeno, H.; Navarrete, M.; Vial, P. A.; Palma, R. E.; Ferres, M.; Cook, J. A.; Hjelle, B. (2008). "Ecology, Genetic Diversity, and Phylogeographic Structure of Andes Virus in Humans and Rodents in Chile". Journal of Virology 83 (6): 2446–2459. doi:10.1128/JVI.01057-08. PMC 2648280. PMID 19116256. 
  18. ^ "Hantavirus Pulmonary Syndrome (HPS) Cases, by State". CDC. July 9, 2010. Retrieved 09-11-2010. 
  19. ^ "Yosemite extends hantavirus warning; death toll rises". 7 September 2012. Retrieved 7 September 2012. 
  20. ^ http://www.newsday.com/entertainment/tv/hard-times-lost-on-long-island-review-1.3824405
  21. ^ Kang, H. J.; Bennett, S. N.; Hope, A. G.; Cook, J. A.; Yanagihara, R. (2011). "Shared Ancestry between a Newfound Mole-Borne Hantavirus and Hantaviruses Harbored by Cricetid Rodents". Journal of Virology 85 (15): 7496–7503. doi:10.1128/JVI.02450-10. PMC 3147906. PMID 21632770. 
  22. ^ Kariwa, H.; Yoshida, H.; Sánchez-Hernández, C.; Romero-Almaraz Mde, M. A. D. L.; Almazán-Catalán, J. A.; Ramos, C.; Miyashita, D.; Seto, T.; Takano, A.; Totani, M.; Murata, R.; Saasa, N.; Ishizuka, M.; Sanada, T.; Yoshii, K.; Yoshimatsu, K.; Arikawa, J.; Takashima, I. (2012). "Genetic diversity of hantaviruses in Mexico: Identification of three novel hantaviruses from Neotominae rodents". Virus Research 163 (2): 486–494. doi:10.1016/j.virusres.2011.11.013. PMID 22138671. 
  23. ^ "Death caused by Hantavirus in west central Saskatchewan". CKOM News. 26 June 2013. Retrieved 04-08-2014. 
  24. ^ Vapalahti, O.; Mustonen, J.; Lundkvist, A.; Henttonen, H.; Plyusnin, A.; Vaheri, A. (2003). "Hantavirus infections in Europe". The Lancet infectious diseases 3 (10): 653–661. doi:10.1016/S1473-3099(03)00774-6. PMID 14522264. 
  25. ^ Klempa, B.; Witkowski, P. T.; Popugaeva, E.; Auste, B.; Koivogui, L.; Fichet-Calvet, E.; Strecker, T.; Ter Meulen, J.; Krüger, D. H. (2012). "Sangassou Virus, the First Hantavirus Isolate from Africa, Displays Genetic and Functional Properties Distinct from Those of Other Murinae-Associated Hantaviruses". Journal of Virology 86 (7): 3819–3827. doi:10.1128/JVI.05879-11. PMC 3302504. PMID 22278233. 
  26. ^ a b c "Hantavirus: Canadian Lung Association". Canadian Lung Association. 18 August 2009. Retrieved 17 March 2011. 
  27. ^ a b c Plyusnin, A.; Vapalahti, O.; Vaheri, A. (1996). "Hantaviruses: Genome structure, expression and evolution". Journal of General Virology 77 (11): 2677. doi:10.1099/0022-1317-77-11-2677. 
  28. ^ a b Jonsson, C. B.; Figueiredo, L. T. M.; Vapalahti, O. (2010). "A Global Perspective on Hantavirus Ecology, Epidemiology, and Disease". Clinical Microbiology Reviews 23 (2): 412–441. doi:10.1128/CMR.00062-09. PMC 2863364. PMID 20375360. 
  29. ^ Elliott, R. M. (1990). "Molecular biology of the Bunyaviridae". The Journal of general virology. 71 ( Pt 3) (3): 501–522. doi:10.1099/0022-1317-71-3-501. PMID 2179464. 
  30. ^ Mir, M. A.; Panganiban, A. T. (2005). "The Hantavirus Nucleocapsid Protein Recognizes Specific Features of the Viral RNA Panhandle and is Altered in Conformation upon RNA Binding". Journal of Virology 79 (3): 1824–1835. doi:10.1128/JVI.79.3.1824-1835.2005. PMC 544099. PMID 15650206. 
  31. ^ Peters, C.J. (2006). "Emerging Infections: Lessons from the Viral Hemorrhagic Fevers". Transactions of the American Clinical and Climatological Association (Transactions of the American Clinical and Climatological Association) 117: 189–197. PMC 1500910. 
  32. ^ Crowley, J.; Crusberg, T. "Ebola and Marburg Virus Genomic Structure, Comparative and Molecular Biology". Dept. of Biology & Biotechnology, Worcester Polytechnic Institute. 
  33. ^ Jackson, A. P.; Charleston, M. A. (2003). "A Cophylogenetic Perspective of RNA-Virus Evolution". Molecular Biology and Evolution 21 (1): 45–57. doi:10.1093/molbev/msg232. PMID 12949128. 
  34. ^ a b c d Ramsden, C.; Holmes, E. C.; Charleston, M. A. (2008). "Hantavirus Evolution in Relation to Its Rodent and Insectivore Hosts: No Evidence for Codivergence". Molecular Biology and Evolution 26 (1): 143–153. doi:10.1093/molbev/msn234. PMID 18922760. 
  35. ^ Delfraro, A.; Tomé, L.; d'Elía, G.; Clara, M.; Achával, F.; Russi, J. C.; Rodonz, J. R. (2008). "Juquitiba-like Hantavirus from 2 Nonrelated Rodent Species, Uruguay". Emerging Infectious Diseases 14 (9): 1447–1451. doi:10.3201/eid1409.080455. PMC 2603116. PMID 18760017.  edit
  36. ^ Plyusnina, A.; Ibrahim, I. -N.; Plyusnin, A. (2009). "A newly recognized hantavirus in the Asian house rat (Rattus tanezumi) in Indonesia". Journal of General Virology 90 (Pt 1): 205–209. doi:10.1099/Vir.0.006155-0. PMID 19088290. 
  37. ^ a b Schmidt-Chanasit, J.; Essbauer, S.; Petraityte, R.; Yoshimatsu, K.; Tackmann, K.; Conraths, F. J.; Sasnauskas, K.; Arikawa, J.; Thomas, A.; Pfeffer, M.; Scharninghausen, J. J.; Splettstoesser, W.; Wenk, M.; Heckel, G.; Ulrich, R. G. (2009). "Extensive Host Sharing of Central European Tula Virus". Journal of Virology 84 (1): 459–474. doi:10.1128/Jvi.01226-09. PMC 2798396. PMID 19889769. 
  38. ^ Ramsden, C.; Melo, F. L.; Figueiredo, L. M.; Holmes, E. C.; Zanotto, P. M. A.; Vgdn, C. (2008). "High Rates of Molecular Evolution in Hantaviruses". Molecular Biology and Evolution 25 (7): 1488–1492. doi:10.1093/molbev/msn093. PMID 18417484. 
  39. ^ a b Kang, H. J.; Bennett, S. N.; Hope, A. G.; Cook, J. A.; Yanagihara, R. (2011). "Shared Ancestry between a Newfound Mole-Borne Hantavirus and Hantaviruses Harbored by Cricetid Rodents". Journal of Virology 85 (15): 7496–7503. doi:10.1128/JVI.02450-10. PMC 3147906. PMID 21632770. 
  40. ^ Song, J. W.; Baek, L. J.; Schmaljohn, C. S.; Yanagihara, R. (2007). "Thottapalayam Virus, a Prototype Shrewborne Hantavirus". Emerging Infectious Diseases 13 (7): 980–985. doi:10.3201/eid1307.070031. PMC 2254531. PMID 18214168. 
  41. ^ Song, J. W.; Kang, H. J.; Song, K. J.; Truong, T. T.; Bennett, S. N.; Arai, S.; Truong, N. U.; Yanagihara, R. (2007). "Newfound Hantavirus in Chinese Mole Shrew, Vietnam". Emerging Infectious Diseases 13 (11): 1784–1787. doi:10.3201/eid1311.070492. PMC 2262106. PMID 18217572. 
  42. ^ Souza WM, Bello G, Amarilla AA, Alfonso HL, Aquino VH, Figueiredo LT (2013) Phylogeography and evolutionary history of rodent-borne hantaviruses. Infect Genet Evol. 2013 Nov 25. pii: S1567-1348(13)00431-0. doi:10.1016/j.meegid.2013.11.015
  43. ^ Park, K.; Kim, C. S.; Moon, K. T. (2004). "Protective Effectiveness of Hantavirus Vaccine". Emerging Infectious Diseases 10 (12): 2218–2220. doi:10.3201/eid1012.040684. PMC 3323375. PMID 15663866. 
Creative Commons Attribution Share Alike 3.0 (CC BY-SA 3.0)

Source: Wikipedia

Unreviewed

Article rating from 0 people

Default rating: 2.5 of 5

Hantavirus pulmonary syndrome

Hantavirus pulmonary syndrome (HPS) is one of two potentially fatal syndromes of zoonotic origin caused by species of hantavirus.[1] These include Black Creek Canal virus (BCCV), New York virus (NYV), Sin Nombre virus (SNV), and certain other members of Hantavirus genera that are native to the United States and Canada.[2] Specific rodents are the principal hosts of the hantaviruses; they include the hispid cotton rat (Sigmodon hispidus) in southern Florida, which is the principal host of Black Creek Canal virus.[3][4] The deer mouse (Peromyscus maniculatus) in Canada and the Western United States is the principal host of Sin Nombre virus.[5][6] The white-footed mouse (Peromyscus leucopus) in the eastern United States is the principal host of New York virus.[7]

Epidemiology[edit]

Hantavirus pulmonary syndrome was first recognized during the 1993 outbreak in the Four Corners region of the southwestern United States. It was identified by Dr. Bruce Tempest. It was originally called "Four Corners disease," but the name was changed to Sin Nombre virus after complaints by Native Americans that the name 'Four Corners' stigmatized the region.[8] It has since been identified throughout the United States.

Transmission[edit]

The hispid cotton rat, indigenous to southern Florida, is the carrier of the Black Creek Canal virus

Transmission by aerosolized rodent excreta still remains the only known way the virus is transmitted to humans. In general, droplet and/or fomite transfer has not been shown in the hantaviruses in either the pulmonary or hemorrhagic forms.[9][10]

Signs and symptoms[edit]

Prodromal symptoms include flu-like symptoms such as fever, cough, myalgia, headache, lethargy and shortness-of-breath, which rapidly deteriorates into acute respiratory failure. It is characterized by the sudden onset of shortness-of-breath with rapidly evolving pulmonary edema; it is often fatal despite mechanical ventilation and intervention with potent diuretics. It has a fatality rate of 38%.

Treatment[edit]

There is no cure or vaccine for HPS. Treatment involves supportive therapy, including mechanical ventilation with supplemental oxygen during the critical respiratory-failure stage of the illness. Early recognition of HPS and admission to an intensive care setting offers the best prognosis.

Prevention[edit]

Rodent control in and around the home or dwellings remains the primary prevention strategy, as well as eliminating contact with rodents in the workplace and campsite. Closed storage sheds and cabins are often ideal sites for rodent infestations. Airing out of such spaces prior to use is recommended. People are advised to avoid direct contact with rodent droppings and wear a mask while cleaning such areas to avoid inhalation of aerosolized rodent secretions.[11]

See also[edit]

References[edit]

  1. ^ Koster FT. Levy H. "Hantavirus cardiopulmonary syndrome: a new twist to an established pathogen", In: Fong IW, editor; Alibek K, editor. New and Evolving Infections of the 21st Century, New York: Springer-Verlag New York, Inc.; 2006. pp. 151–170.
  2. ^ Nichol ST. Beaty BJ. Elliott RM. Goldbach R, et al. Family Bunyaviridae. In: Fauquet CM, editor; Mayo MA, editor; Maniloff J, editor; Desselberger U, et al., editors. Virus Taxonomy: 8th Report of the International Committee on Taxonomy of Viruses. San Diego, CA: Elsevier Academic Press;
  3. ^ Rollin PE. Ksiazek TG. Elliott LH. Ravkov EV, et al. "Isolation of Black Creek Canal virus, a new hantavirus from Sigmodon hispidus in Florida", J Med Virol. 1995;46:35–39. [PubMed]
  4. ^ Glass GE. Livingstone W. Mills JN. Hlady WG, et al. "Black Creek Canal virus infection in Sigmodon hispidus in southern Florida", Am J Trop Med Hyg. 1998;59:699–703. PubMed
  5. ^ Childs JE. Ksiazek TG. Spiropoulou CF. Krebs JW, et al. "Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States", J Infect Dis. 1994;169:1271–1280. [PubMed]
  6. ^ Drebot MA. Gavrilovskaya I. Mackow ER. Chen Z, et al. "Genetic and serotypic characterization of Sin Nombre-like viruses in Canadian Peromyscus maniculatus mice", Virus Res. 2001;75:75–86. [PubMed]
  7. ^ Hjelle B. Lee SW. Song W. Torrez-Martinez N, et al. "Molecular linkage of hantavirus pulmonary syndrome to the white-footed mouse, Peromyscus leucopus: genetic characterization of the M genome of New York virus", J Virol. 1995;69:8137–8141. [PMC free article] [PubMed]
  8. ^ "Death at the Corners". Discover Magazine. 1993-12-01. Retrieved 2013-03-25. 
  9. ^ Peters, C.J. (2006). "Emerging Infections: Lessons from the Viral Hemorrhagic Fevers". Transactions of the American Clinical and Climatological Association (Transactions of the American Clinical and Climatological Association) 117: 189–197. 
  10. ^ Crowley, J.; Crusberg, T. "Ebola and Marburg Virus Genomic Structure, Comparative and Molecular Biology". Dept. of Biology & Biotechnology, Worcester Polytechnic Institute. 
  11. ^ "CDC - Hantavirus Pulmonary Syndrome (HPS) - Hantavirus". Cdc.gov. 2013-02-06. Retrieved 2013-07-07. 
Creative Commons Attribution Share Alike 3.0 (CC BY-SA 3.0)

Source: Wikipedia

Unreviewed

Article rating from 0 people

Default rating: 2.5 of 5

Hantavirus hemorrhagic fever with renal syndrome

Hantavirus hemorrhagic fever with renal syndrome (HFRS) is a group of clinically similar illnesses caused by species of hantaviruses from the family Bunyaviridae. It is also known as Korean hemorrhagic fever, epidemic hemorrhagic fever, and nephropathis epidemica. The species that cause HFRS include Hantaan River virus, Dobrava-Belgrade, Saaremaa, Seoul, Puumala and other hantaviruses. It is found in Europe, Asia, and Africa.[1] Of these species, Hantaan River virus and Dobrava-Belgrade virus cause the most severe form of the syndrome and have the highest morbidity rates.

Both hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS) appear to be immunopathologic, and inflammatory mediators are important in causing the clinical manifestations.

Epidemiology[edit]

HFRS is primarily a Eurasian disease, whereas HPS appears to be confined to the Americas. The geography is directly related to the indigenous rodent hosts and the viruses that coevolved with them.[2]

Transmission[edit]

Transmission by aerosolized rodent excreta still remains the only known way the virus is transmitted to humans. In general, droplet and/or fomite transfer has not been shown in the hantaviruses in either the pulmonary or hemorrhagic forms.[3][4]

Signs and symptoms[edit]

Symptoms of HFRS usually develop within 1 to 2 weeks after exposure to infectious material, but in rare cases, they may take up to 8 weeks to develop. Initial symptoms begin suddenly and include intense headaches, back and abdominal pain, fever, chills, nausea, and blurred vision. Individuals may have flushing of the face, inflammation or redness of the eyes, or a rash. Later symptoms can include low blood pressure, acute shock, vascular leakage, and acute kidney failure, which can cause severe fluid overload.

The severity of the disease varies depending upon the virus causing the infection. Hantaan and Dobrava virus infections usually cause severe symptoms, while Seoul, Saaremaa, and Puumala virus infections are usually more moderate. Complete recovery can take weeks or months.[5]

The course of the illness can be split into five phases:

  • Febrile phase: Symptoms include redness of cheeks and nose, fever, chills, sweaty palms, diarrhea, malaise, headaches, nausea, abdominal and back pain, respiratory problems such as the ones common in the influenza virus, as well as gastro-intestinal problems. These symptoms normally occur for three to seven days and arise about two to three weeks after exposure.
  • Hypotensive phase: This occurs when the blood platelet levels drop and symptoms can lead to tachycardia and hypoxemia. This phase can last for 2 days.
  • Oliguric phase: This phase lasts for three to seven days and is characterised by the onset of renal failure and proteinuria.
  • Diuretic phase: This is characterized by diuresis of three to six litres per day, which can last for a couple of days up to weeks.
  • Convalescent phase: This is normally when recovery occurs and symptoms begin to improve.

This syndrome can also be fatal. In some cases, it has been known to cause permanent renal failure.[6]

Diagnosis[edit]

HFRS is difficult to diagnose on clinical grounds alone and serological evidence is often needed. A fourfold rise in IgG antibody titer in a 1-week interval, and the presence of the IgM type of antibodies against hantaviruses are good evidence for an acute hantavirus infection. HFRS should be suspected in patients with acute febrile flu-like illness, renal failure of unknown origin and sometimes hepatic dysfunction.[7]

Treatment[edit]

There is no cure or vaccine for HFRS. Treatment involves supportive therapy including renal dialysis. Treatment with ribavirin in China and Korea, administered within 7 days of onset of fever, resulted in a reduced mortality as well as shortened course of illness.[8]

Prevention[edit]

Rodent control in and around the home remains the primary prevention strategy, as well as eliminating contact with rodents in the workplace and campsite. Closed storage sheds and cabins are often ideal sites for rodent infestations. Airing out of such spaces prior to use is recommended. Avoid direct contact with rodent droppings and wear a mask to avoid inhalation of aerosolized rodent secretions.[9]

See also[edit]

Creative Commons Attribution Share Alike 3.0 (CC BY-SA 3.0)

Source: Wikipedia

Unreviewed

Article rating from 0 people

Default rating: 2.5 of 5

Prospect Hill virus

Prospect Hill virus is a single-stranded, negative-sense Hantaan-like zoonotic RNA virus isolated from meadow voles and microtine and crietid rodents in the United States. It has a widespread distribution in Pennsylvania, Maryland, West Virginia, Minnesota and California. The overall risk of infection in humans is low. It was first isolated from a meadow vole found in Prospect Hill, Maryland for which it is named. [1]

Transmission[edit]

Transmission to humans is believed to occur through aersolized inhalation of mouse excreta and possibly through fomite contamination.

See also[edit]

References[edit]

  1. ^ Yanagihara R, Daum CA, Lee PW, Baek LJ, Amyx HL, Gajdusek DC, Gibbs CJ Jr.Serological survey of Prospect Hill virus infection in indigenous wild rodents in the USA.Trans R Soc Trop Med Hyg. 1987;81(1):42-5.
Creative Commons Attribution Share Alike 3.0 (CC BY-SA 3.0)

Source: Wikipedia

Unreviewed

Article rating from 0 people

Default rating: 2.5 of 5

Monongahela virus

Monongahela virus (MGLV) is a single-stranded, negative-sense RNA Hantavirus species of zoonotic origin that causes Hantavirus pulmonary syndrome.[1] The virus was first isolated from a White-footed mouse (Peromyscus leucopus), indigenous to Pennsylvania after two residents died from rapid onset of respiratory failure.

Discovery of virus[edit]

Monongahela virus was first detected in P. maniculatus nubiterrae (Cloudland deer mice) captured in the Monongahela National Forest in West Virginia in 1985.[2]

Transmission[edit]

This species of Hantavirus has not been shown to transfer from person to person. Transmission by aerosolized rodent excreta still remains the only known way the virus is transmitted to humans. In general, drop-let and/or fomite transfer has not been shown in the hantaviruses in either the hemorrhagic or pulmonary forms.[3][4]

In both cases in Pennsylvania, the patients were living in rural areas and had recent exposure to rodent excreta prior to the onset of symptoms. Both patients developed rapid onset of respiratory distress and pulmonary edema, believed to be the result of cytokine storm, and both expired within 5 days of onset of symptoms.

See also[edit]

References[edit]

  1. ^ Luther V. Rhodes, Cinnia Huang, Angela J. Sanchez, Stuart T. Nichol§, Sherif R. Zaki§, Thomas G. Ksiazek, J.G. Humphreys¶, James J. Freeman*, and Kenneth R. Knecht. Hantavirus Pulmonary Syndrome Associated with Monongahela Virus, Pennsylvania. Research. Volume 6, Number 6—December 2000.
  2. ^ Song JW, Baek LJ, Nagle JW, Schlitter D, Yanagihara R. Genetic and phylogenetic analysis of hantaviral sequences amplified from archival tissues of deer mice (Peromyscus maniculatus nubiterrae) captured in the eastern United States. Arch Virol. 1996;141:959–67.
  3. ^ Peters, C.J. (2006). "Emerging Infections: Lessons from the Viral Hemorrhagic Fevers". Transactions of the American Clinical and Climatological Association (Transactions of the American Clinical and Climatological Association) 117: 189–197. PMC 1500910. 
  4. ^ Crowley, J.; Crusberg, T. "Ebola and Marburg Virus Genomic Structure, Comparative and Molecular Biology". Dept. of Biology & Biotechnology, Worcester Polytechnic Institute. 
Creative Commons Attribution Share Alike 3.0 (CC BY-SA 3.0)

Source: Wikipedia

Unreviewed

Article rating from 0 people

Default rating: 2.5 of 5

Muju virus

Muju virus (MUV) is a zoonotic negative sense single-stranded RNA virus species of the genus Hantavirus. It is one of four rodent-borne Hantaviruses found in the Republic of Korea. It is the etiologic agent for Hantavirus hemorrhagic fever with renal syndrome (HFRS). The other species responsible for HFRS in Korea are Seoul virus, Haantan virus, and Soochong virus.[1][2]

Transmission[edit source | edit]

This species of Hantavirus has not been shown to transfer from person to person. Transmission by aerosolized rodent excreta still remains the only known way the virus is transmitted to humans. In general, drop-let and/or fomite transfer has not been shown in the hantaviruses in either the hemorrhagic or pulmonary forms.[3][4]

See also[edit source | edit]

References[edit source | edit]

  1. ^ Song KJ, Baek LJ, Moon S, Ha SJ, Kim SH, Park KS, Klein TA, Sames W, Kim HC, Lee JS, Yanagihara R, Song JW.Muju virus, a novel hantavirus harboured by the arvicolid rodent Myodes regulus in Korea.J Gen Virol. 2007 Nov;88(Pt 11):3121-9.
  2. ^ Song, Jin-Won; Moon, Sung-Sil; Gu, Se Hun; Song, Ki-Joon; Baek, Luck Ju; Kim, Heung Chul; Kijek, Tod. Hemorrhagic fever with renal syndrome in 4 US soldiers, South Korea. Emerging Infectious Diseases. J Med Virol. 2006 Feb;78(2):290-7.
  3. ^ Peters, C.J. (2006). "Emerging Infections: Lessons from the Viral Hemorrhagic Fevers". Transactions of the American Clinical and Climatological Association (Transactions of the American Clinical and Climatological Association) 117: 189–197. PMC 1500910. 
  4. ^ Crowley, J.; Crusberg, T. "Ebola and Marburg Virus Genomic Structure, Comparative and Molecular Biology". Dept. of Biology & Biotechnology, Worcester Polytechnic Institute. 
Creative Commons Attribution Share Alike 3.0 (CC BY-SA 3.0)

Source: Wikipedia

Unreviewed

Article rating from 0 people

Default rating: 2.5 of 5

Soochong virus

Soochong virus (SOO) is a zoonotic negative sense single-stranded RNA virus species of the genus Hantavirus. It is one of four rodent-borne Hantaviruses found in the Republic of Korea. It is the etiologic agent for Hantavirus hemorrhagic fever with renal syndrome (HFRS). The other species responsible for HFRS in Korea are Seoul virus, Haantan virus, and Muju virus.[1]

Soochong was isolated from four Korean field mice (Apodemus peninsulae) captured in August 1997 at Mt. Gyebang in Hongcheon-gun, Mt. Gachil, Inje-gun, Gangwon Province, and in September 1998 at Mt. Deogyu, Muju-gun, Jeollabuk Province.

Transmission[edit source | edit]

This species of Hantavirus has not been shown to transfer from person-to-person. Transmission by aerosolized rodent excreta still remains the only known way the virus is transmitted to humans. In general, drop-let and/or fomite transfer has not been shown in the hantaviruses in either the hemorrhagic or pulmonary forms.[2][3]

See also[edit source | edit]

References[edit source | edit]

  1. ^ Song, Jin-Won; Moon, Sung-Sil; Gu, Se Hun; Song, Ki-Joon; Baek, Luck Ju; Kim, Heung Chul; Kijek, Tod. Hemorrhagic fever with renal syndrome in 4 US soldiers, South Korea. Emerging Infectious Diseases. J Med Virol. 2006 Feb;78(2):290-7.
  2. ^ Peters, C.J. (2006). "Emerging Infections: Lessons from the Viral Hemorrhagic Fevers". Transactions of the American Clinical and Climatological Association (Transactions of the American Clinical and Climatological Association) 117: 189–197. PMC 1500910. 
  3. ^ Crowley, J.; Crusberg, T. "Ebola and Marburg Virus Genomic Structure, Comparative and Molecular Biology". Dept. of Biology & Biotechnology, Worcester Polytechnic Institute. 
Creative Commons Attribution Share Alike 3.0 (CC BY-SA 3.0)

Source: Wikipedia

Unreviewed

Article rating from 0 people

Default rating: 2.5 of 5

Disclaimer

EOL content is automatically assembled from many different content providers. As a result, from time to time you may find pages on EOL that are confusing.

To request an improvement, please leave a comment on the page. Thank you!